Skip to content

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$608.24M-29.8%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$293.6M+33.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$1.37B+55.5%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$636.13M+3.4%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.21B+475%
Enterprise value$2.16B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s total assets?
MBX Biosciences, Inc. (MBX) reported total assets of $452.7M in Q1 2026.
How has MBX Biosciences, Inc.'s total assets changed year-over-year?
MBX Biosciences, Inc.'s total assets increased by 84.1% year-over-year, from $245.93M to $452.7M.
What is the long-term trend for MBX Biosciences, Inc.'s total assets?
Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s total assets has grown at a 113.9% compound annual growth rate (CAGR), from $84.18M to $385.14M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.